Crossmark

Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1038/mp.2017.41

Published Online: 2017-03-14

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Roffman, J L

Petruzzi, L J

Tanner, A S

Brown, H E

Eryilmaz, H

Ho, N F

Giegold, M

Silverstein, N J

Bottiglieri, T

Manoach, D S

Smoller, J W

Henderson, D C

Goff, D C
License Information

Text and Data Mining valid from 2017-03-14
More Information

Article History

Received: 23 January 2017

Accepted: 26 January 2017

First Online: 14 March 2017

Competing interests

: JLR reports receiving grant support for this study from Pamlab, and has served as a consultant for Pamlab. TB reports receiving grant support for this study from Pamlab. JWS is an unpaid member of the Scientific Advisory Board of PsyBrain. DCH reports personal fees from Otsuka Phamaceutical, McLean Hospital and Global CME; and grants from Novartis, Forum and Reckitt Benckiser; all outside the submitted work. DCG reports receiving grant support for this study from Pamlab. The remaining authors report no biomedical financial interests or potential conflicts of interest.